These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30134053)

  • 41. Author's Institutional Affiliation Incorrect in the Letter by Liu et al (Arthritis Rheumatol, April 2020).
    Arthritis Rheumatol; 2020 Jun; 72(6):1035. PubMed ID: 32460424
    [No Abstract]   [Full Text] [Related]  

  • 42. Errata.
    Arthritis Rheumatol; 2016 Feb; 68(2):515. PubMed ID: 26808829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lesinurad for the treatment of hyperuricaemia in people with gout.
    Robinson PC; Dalbeth N
    Expert Opin Pharmacother; 2017 Dec; 18(17):1875-1881. PubMed ID: 29103339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two findings of portal hypertension: evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis.
    Demirel U; Karincaoğlu M; Harputluoğlu M; Ateş M; Seçkin Y; Yildirim B; Hilmioğlu F
    Turk J Gastroenterol; 2003 Dec; 14(4):219-22. PubMed ID: 15048594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Errata.
    Arthritis Rheumatol; 2016 Feb; 68(2):515. PubMed ID: 26808828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential diagnostic perspectives provided by en face microscopic examination of articular surface defects.
    Rothschild BM
    Clin Rheumatol; 2018 Mar; 37(3):831-836. PubMed ID: 29399706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Error in Text Describing Findings of Referenced Study in the Editorial by Hsu (Arthritis Rheumatol, May 2019).
    Arthritis Rheumatol; 2019 Jun; 71(6):907. PubMed ID: 31132226
    [No Abstract]   [Full Text] [Related]  

  • 48. Error in the Title of the Article by Lee et al (Arthritis Care Res, December 2010), Error in Conclusion for the Article by Beltai et al (Arthritis Care Res, December 2018).
    Arthritis Care Res (Hoboken); 2022 Jan; 74(1):88. PubMed ID: 34967510
    [No Abstract]   [Full Text] [Related]  

  • 49. Febuxostat for Patients With Gout and Severe Chronic Kidney Disease: Which Is the Appropriate Dosage? Comment on the Article by Saag et al.
    Quilis N; Andrés M; Gil S; Ranieri L; Vela P; Pascual E
    Arthritis Rheumatol; 2016 Oct; 68(10):2563-4. PubMed ID: 27273838
    [No Abstract]   [Full Text] [Related]  

  • 50. Probable osteosarcoma risk after prolonged teriparatide treatment: comment on the article by Saag et al.
    Tastekin N; Zateri C
    Arthritis Rheum; 2010 Jun; 62(6):1837; author reply 1837-8. PubMed ID: 20191586
    [No Abstract]   [Full Text] [Related]  

  • 51. Heterozygosity of the 721.221-B*51:01 Cell Line Used in the Study by Guasp et (Arthritis Rheumatol, February 2016).
    Arthritis Rheumatol; 2017 Mar; 69(3):686. PubMed ID: 28239991
    [No Abstract]   [Full Text] [Related]  

  • 52. Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension.
    Gurubacharya DL; Mathura KC; Karki DB
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):327-33. PubMed ID: 16449830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension.
    Torres E; Barros P; Calmet F
    Am J Gastroenterol; 1998 Nov; 93(11):2172-8. PubMed ID: 9820392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
    Khandwalla HE; Fasakin Y; El-Serag HB
    Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
    Saag KG; Fitz-Patrick D; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; Becker MA
    Arthritis Rheumatol; 2017 Jan; 69(1):203-212. PubMed ID: 27564409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment.
    Shen Z; Tieu K; Wilson D; Bucci G; Gillen M; Lee C; Kerr B
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):377-387. PubMed ID: 28074640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lesinurad: A Review in Hyperuricaemia of Gout.
    Deeks ED
    Drugs Aging; 2017 May; 34(5):401-410. PubMed ID: 28425024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide.
    Gillen M; Yang C; Wilson D; Valdez S; Lee C; Kerr B; Shen Z
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):363-376. PubMed ID: 28067999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
    Gillen M; Valdez S; Zhou D; Kerr B; Lee CA; Shen Z
    Drug Des Devel Ther; 2016; 10():3555-3562. PubMed ID: 27843295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
    Tausche AK; Alten R; Dalbeth N; Kopicko J; Fung M; Adler S; Bhakta N; Storgard C; Baumgartner S; Saag K
    Rheumatology (Oxford); 2017 Dec; 56(12):2170-2178. PubMed ID: 29029210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.